FDA Panel Recommends a Covid Vaccine Aimed at Only the XBB Variant

The New York Times - Business:

An F.D.A. advisory panel told manufacturers to aim the latest coronavirus vaccine for the fall at the dominant SARS-CoV-2 variant.

Author: Christina Jewett

This post first appeared in The New York Times - Business. Read the original article.